Pieter Evenepoel1,2, Etienne Cavalier3, Patrick C D'Haese4. 1. Department of Immunology and Microbiology, Laboratory of Nephrology, KU Leuven, 3000, Leuven, Belgium. pieter.evenepoel@uzleuven.be. 2. Department of Nephrology and Renal Transplantation, University Hospitals Leuven, 3000, Leuven, Belgium. pieter.evenepoel@uzleuven.be. 3. Department of Clinical Chemistry, University of Liege, CHU de Liege, 4000, Liege, Belgium. 4. Department of Biomedical Sciences, Laboratory of Pathophysiology, Antwerp University, 2610, Wilrijk, Belgium.
Abstract
PURPOSE OF THE REVIEW: Impaired bone quality contributes to the increased fracture risk in chronic kidney disease patients. Both low and high turnover bone disease may compromise bone quality. The question arises whether bone biomarkers may be additive or replace bone histormorphometry for diagnosing the extremes of bone turnover. RECENT FINDINGS: Studies exploring the performance of established and emerging bone biomarkers against histomorphometric assessment of bone turnover are limited and overall yield inconclusive results as to their diagnostic utility. Bone biomarkers, although promising, currently fail to meet the needed diagnostic accuracy to replace bone histomorphometry and thus are not yet ready for clinical use. Bone biomarkers have not only several advantages, but also important limitations such as high biological variability, retention with kidney disease, preanalytical issues, and interassay variability. These important issues must be considered when developing and evaluating bone biomarkers. There is an urgent need for harmonization and standardization of available assays and additional bone biopsy studies.
PURPOSE OF THE REVIEW: Impaired bone quality contributes to the increased fracture risk in chronic kidney diseasepatients. Both low and high turnover bone disease may compromise bone quality. The question arises whether bone biomarkers may be additive or replace bone histormorphometry for diagnosing the extremes of bone turnover. RECENT FINDINGS: Studies exploring the performance of established and emerging bone biomarkers against histomorphometric assessment of bone turnover are limited and overall yield inconclusive results as to their diagnostic utility. Bone biomarkers, although promising, currently fail to meet the needed diagnostic accuracy to replace bone histomorphometry and thus are not yet ready for clinical use. Bone biomarkers have not only several advantages, but also important limitations such as high biological variability, retention with kidney disease, preanalytical issues, and interassay variability. These important issues must be considered when developing and evaluating bone biomarkers. There is an urgent need for harmonization and standardization of available assays and additional bone biopsy studies.
Entities:
Keywords:
Bone biomarkers; Bone formation; Bone histomorphometry; Bone resorption; Bone turnover; Chronic kidney disease; Diagnostic performance; Non-invasive diagnosis; Renal osteodystrophy
Authors: Johann Herberth; Adam J Branscum; Hanna Mawad; Tom Cantor; Marie-Claude Monier-Faugere; Hartmut H Malluche Journal: Am J Kidney Dis Date: 2010-03-27 Impact factor: 8.860
Authors: P Ureña; A Ferreira; V T Kung; C Morieux; P Simon; K S Ang; J C Souberbielle; G V Segre; T B Drüeke; M C De Vernejoul Journal: J Bone Miner Res Date: 1995-06 Impact factor: 6.741
Authors: Sunita Sardiwal; Clare Gardham; Adrian E Coleman; Paul E Stevens; Michael P Delaney; Edmund J Lamb Journal: Kidney Int Date: 2012-03-28 Impact factor: 10.612
Authors: Francesca Tentori; Keith McCullough; Ryan D Kilpatrick; Brian D Bradbury; Bruce M Robinson; Peter G Kerr; Ronald L Pisoni Journal: Kidney Int Date: 2013-07-31 Impact factor: 10.612
Authors: Isabelle Piec; Christopher Washbourne; Jonathan Tang; Emily Fisher; Julie Greeves; Sarah Jackson; William D Fraser Journal: Calcif Tissue Int Date: 2016-01-09 Impact factor: 4.333
Authors: Jordi Bover; Pablo Ureña-Torres; Mario Cozzolino; Minerva Rodríguez-García; Carlos Gómez-Alonso Journal: Calcif Tissue Int Date: 2021-01-04 Impact factor: 4.333
Authors: Maria Fusaro; Giulia Vanessa Re Sartò; Maurizio Gallieni; Laura Cosmai; Piergiorgio Messa; Maurizio Rossini; Iacopo Chiodini; Mario Plebani; Pieter Evenepoel; Nicholas Harvey; Serge Ferrari; Jorge Cannata-Andía; Andrea Trombetti; Maria Luisa Brandi; Markus Ketteler; Thomas L Nickolas; John Cunningham; Syazrah Salam; Carlo Della Rocca; Aldo Scarpa; Salvatore Minisola; Fabio Malberti; Filomena Cetani; Mario Cozzolino; Sandro Mazzaferro; Luigi Morrone; Giovanni Tripepi; Martina Zaninotto; Maria Cristina Mereu; Maura Ravera; Giuseppe Cianciolo; Gaetano La Manna; Andrea Aghi; Sandro Giannini; Luca Dalle Carbonare Journal: Nutrients Date: 2022-04-22 Impact factor: 6.706